|MARK YOUR CALENDER|
|Friday, May 13, 2016
Sheraton Toronto Airport Hotel & Conference Centre
Friday, May 13, 2016
Co-Chairs: Lawrence Leiter, MD & Peter Lin, MD
|7:30 am||Breakfast and Registration|
|8:15||Introduction and Welcome||Lawrence Leiter, MD|
|8:25||Current management of Hyperglycemia: How should we use all of the new agents?||Alice Cheng, MD|
|8:45||The New Cardiovascular Trials in Diabetes: Implications for therapy||Lawrence Leiter, MD|
|9:05||Diagnosis and Management of Hypertension in light of SPRINT||Sheldon Tobe, MD|
|9:25||Treatment of Obesity in Diabetes||Ronald Goldenberg, MD|
|9:45||Panel Discussion and Audience Q & A||Faculty|
|10:35||New Canadian Lipid Guidelines: What do they mean for your practice?||Peter Lin, MD|
|10:55||Real World Data on High Risk T2DM Patient Management: Can we do better?||Lawrence Leiter, MD|
|11:15||The Role of PCSK9 Inhibitors and New Novel Lipid Lowering Agents in the Management of Dyslipidemia||Shaun Goodman, MD|
|11:35||The Treatment of Diabetes in the Older Adult: How does it differ?||Alice Cheng, MD|
|11:55||Panel Discussion and Audience Q & A||Faculty|
|1:05||Secondary Prevention: Therapeutic suggestions from the Canadian Heart Research Centre||Anatoly Langer, MD|
|1:25||When to Stop/Not Stop the Second Antiplatelet Agent: The answer is in||Shaun Goodman, MD|
|1:45||Heart Failure after Hospital Discharge: New data that everyone needs to know||Anatoly Langer, MD|
|2:05||Panel Discussion and Audience Q & A||Faculty|
|2:25||Case-Based Discussion with Audience and Faculty Interaction of Mr. Typical with HT, DM, and AF post-ACS
||Peter Lin, MD|
|3:30||Evaluation and Adjournment|
Royal College of Physicians and Surgeons of Canada – Section 1:
This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, approved by Continuing Professional Development, Faculty of Medicine, University of Toronto up to a maximum of (6.0 hours)
College of Family Physicians of Canada – Mainpro M1:
This program meets the accreditation criteria of The College of Family Physicians of Canada and has been accredited by Continuing Professional Development, Faculty of Medicine, University of Toronto, for up to 6.0 Mainpro-M1 credits.
Cardio-Metabolic Summit 2016
Program Learning Objectives
By participating in this program, participants will be able to:
- Identify the current management gaps in the treatment of patients with cardiovascular and metabolic disorders.
- Translate evidence-based strategies for prevention, screening, and treatment of cardio-metabolic risk factors and their co-morbidities to individual patient management.
- Identify which interventions, including lifestyle changes and various therapies alone and in combination, are most appropriate for particular patients with diabetes based on their risk profiles and individual preferences.
- Apply optimal strategies for the management of hyperglycemia in patients with individual characteristics, including the elderly and patients with renal dysfunction.
- Identify how novel and emerging therapies can be integrated into clinical practice to reduce morbidity and mortality from cardiovascular causes such as heart failure and stroke.
- Apply the updated Canadian Clinical Practice Guidelines in the context of comprehensive, multi-factorial cardiovascular and metabolic risk reduction strategies to the clinical care of high-risk patients.
- Review evidence based measures for risk factor control including hypertension and dyslipidemia.
- Outline specific steps for cardiovascular risk reduction that should be considered in every patient at risk.